Global /Australia /Healthcare /Drug Manufacturers - Specialty & Generic /VIT
chevron_leftBack
Vitura Health Ltd. logo

Vitura Health Ltd.

VIT
ASX: VIT Delayed
0.0400AUD 5.3%
0.0282 USD
As of 10 June 2026, Vitura Health Ltd. has a market cap of $17.74M USD, ranking #37901 globally and #1129 in Australia. It ranks #3385 in the Healthcare sector, and #215 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
37901
Country Rank
1129
Sector Rank
3385
Industry Rank
215
Key Stats
Market Cap
$17.74MUSD
25.18M AUD
Enterprise Value
$23.91MUSD
33.94M AUD
Revenue (TTM)
$91.05MUSD
129.24M AUD
EBITDA (TTM)
$1.36MUSD
1.93M AUD
Net Income (TTM)
$552.41KUSD
784.13K AUD
EBITDA Margin
1.5%
Profit Margin
0.6%
PE Ratio
31.6
PS Ratio
0.2
PB Ratio
0.6
EV/EBITDA
12.4
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Ryan Tattle open_in_new
Founded
2018
Website
vitura.com.au open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
5.3% 5.3% -14% -30% -39% -42%

News

Loading...

Markets

Exchange Ticker Price
Australian Securities Exchange
MIC: XASX
PRIMARY
VIT
Vitura Health Ltd Ordinary Shares
ISIN: AU0000266801
Shares Out.:
662.742M1 Shares Float: 361.488M2
TV:
SA:
YF:
GF:
BA:
VIT
MS:
0.0400 AUD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Vitura Health Ltd.

Vitura Health Limited engages in the sale and distribution of medicinal cannabis products in Australia. It operates through two segments: Sales and Distribution; and Clinics and Services. The company operates CanView, an online platform that delivers prescribing, dispensing, and medication management solutions for alternative therapies; Doctors on Demand, a premier provider of on-demand virtual healthcare services; BHC, an alternative therapy distributor; CDA Clinics, which provides medicinal consultations and prescription services; and Cannadoc, a therapy clinic that offers telehealth consultations. It also offers psychedelics under the Cortexa brand; Adaya which provides hybrid formulations and Australian-cultivated products; candor medical that provides care to patients; and inscape, which offers crafted formulations for individual needs. The company was formerly known as Cronos Australia Limited and changed its name to Vitura Health Limited in February 2023. Vitura Health Limited was incorporated in 2018 and is based in South Yarra, Australia.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (Australia)
Name
Market Cap diff.
PE
$1.09B
1.55B AUD
6K%
52.7
$121.45M
172.39M AUD
585%
-
$112.9M
160.26M AUD
536%
18.1
$98.75M
140.17M AUD
457%
14.1
$55.7M
79.06M AUD
214%
-
BNIGF
$49.41M
178%
-
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
PE
$37.19B
108.92B ILS
209K%
24.2
$29.56B
167K%
-
$15.86B
107.34B CNY
89K%
16.0
CIPLA
$11.13B
1.06T INR
63K%
23.4
LUPIN
$11.02B
1.05T INR
62K%
22.7
$9.1B
61.6B CNY
51K%
80.6
chevron_leftBack